Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00721188Phase 2Completed
Phase 2, open-label, single-arm trial of iron sucrose in anemia, sponsored by American Regent, Inc. Primary endpoints: Maximum Observed Serum Concentration at 12 hours, Time to Maximum Serum Concentration at 12 hours and 4 more. Started Jan 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00721188.